Genesis IBRC India

Genesis IBRC India FCF Conversion

Delisted·Sep 16, 2026

The FCF Conversion Rate (FCF/EBITDA) of Genesis IBRC India (514336.BO) as of Nov 3, 2026 is -0.01 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 0.03 % — a change of -129.55% (lower).

FCF Conversion

-0.01 %

YoY

-129.55%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Genesis IBRC India is 2025 -0.01 % . FCF Conversion Rate (FCF/EBITDA) of Genesis IBRC India was 2024 0.03 % . It decreases by -129.55% lower compared to the previous year.

The Genesis IBRC India FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2014
-1.50 INR
Jan 1, 2015
1,093.21 INR
Jan 1, 2016
-761.53 INR
Jan 1, 2017
-19,257.16 INR
Jan 1, 2018
-4,945.67 INR
Jan 1, 2023
66.96 INR
Jan 1, 2024
0.03 INR
Jan 1, 2025
-0.01 INR
The Genesis IBRC India FCF Conversion history
YEARFCF ConversionYoY
-0.01 %-129.55%
0.03 %-99.96%
66.96 %-101.35%
-4,945.67 %-74.32%
-19,257.16 %+2,428.75%
-761.53 %-169.66%
1,093.21 %-72,985.78%
-1.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genesis IBRC India Stock analysis

What does Genesis IBRC India do? Genesis IBRC India Ltd. generates revenue through the manufacturing and sale of pro-biotic products for aquaculture and fisheries, including GENPRO-WAT, PRO-VIBSOL, AMMONO-GEN, GENLACT, GROWFAST-GEN, and GEN-POND CLEAN. The company provides formulation research and development services for agriculture, aquaculture, poultry, and veterinary bio formulations, offering need-based product design, land labs, and consultation services. Its primary customers are businesses in aquaculture, fisheries, agriculture, and veterinary sectors seeking specialized pro-biotic solutions and R&D support. The company's product portfolio targets water and soil pro-biotics, vibrio controllers, ammonia and nitrites reducers, gut and intestinal pro-biotics, single cell protein, and fast decomposers. These solutions are designed to address specific challenges in aquatic and agricultural environments, such as water quality management and animal health. The firm's R&D services cater to clients requiring tailored bio-formulation development and technical expertise for their operational needs. Genesis IBRC India is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genesis IBRC India stock

FCF Conversion Rate (FCF/EBITDA) of Genesis IBRC India is -0.01 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Genesis IBRC India changed from 0.03 % to -0.01 %, representing a -129.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Genesis IBRC India since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Genesis IBRC India with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Genesis IBRC India

All Key Metrics — Genesis IBRC India